A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation

Published:2020-06-30 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Chen Hao,Gong Yuanying,Ma Yufang,Thompson Reid C.,Wang Jialiang,Cheng Zhixiang,Xue Lixia

Funder

Shanghai Association for Science and Technology

National Natural Science Foundation of China

American Brain Tumor Association

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference49 articles.

1. CD133 Expression in Glioblastoma Multiforme: A Literature Review;Ahmed;Cureus,2018

2. Glioblastoma: pathology, molecular mechanisms and markers;Aldape;Acta Neuropathol.,2015

3. Targeting DNA repair and the cell cycle in glioblastoma;Alexander;J. Neurooncol.,2012

4. Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling;Bahar;Cancers (Basel),2019

5. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress;Archives of Pharmacal Research;2024-04-17

2. Devitalization of Glioblastoma Cancer Cells by Non-invasive Physical Plasma: Modulation of Proliferative Signalling Cascades;Anticancer Research;2022-12-30

3. Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration;Metabolites;2022-11-21

4. Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials;Cancers;2022-11-04

5. Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy;Cells;2022-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3